🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalAny EU members finding it impossible to get prescribed? — what worked for you?

Any EU members finding it impossible to get prescribed? — what worked for you?

TomFromTexas Sat, Oct 14, 2023 at 1:25 AM 14 replies 2,333 viewsPage 1 of 3
This thread is more than 29 months old. Information may be outdated. Consider searching for more recent discussions.
TomFromTexas
Member
645
2,890
May 2024
Austin, TX
Oct 14, 2023 at 2:50 AM#1

Putting together a summary on any eu members finding it impossible since I keep seeing the same questions pop up.

I am not a medical professional (just a well-researched patient) so take this with appropriate salt, but I have compiled info from this forum and my own experience.

Happy to be corrected by the actual clinicians here — that is the whole point of posting it.

42 24PharmD_Rodriguez, julia.endo, JessicaM_2024 and 39 others
Reply Quote Save Share Report
Dr.KarenChen
VIP Member
4,210
24,567
Nov 2023
San Francisco, CA
Oct 14, 2023 at 3:07 AM#2

Good question. For Any EU members finding it, here is what the evidence says:

  • The clinical trial data (SURMOUNT program) supports this approach
  • Real-world results from this community generally confirm the trial findings
  • Individual variation is real — give it at least 8 weeks before judging

Happy to go deeper on any of these points if helpful.

18 21JessicaM_2024, TomFromTexas, mike.trainer_LA and 15 others
Reply Quote Save Share Report
SkepticalSean
Member
98
345
Jan 2025
Maine
Oct 14, 2023 at 3:24 AM#3
Dr.KarenChen said:
For Any EU members finding it, here is what the evidence says:The clinical trial data (SURMOUNT prog

Completely agree with Dr.KarenChen. I would add that Any EU members finding it also has implications for long-term metabolic health that sometimes get overlooked in these discussions.

In my case, following a similar approach led to significant improvements compared to what I was doing before.

1 9emma_london
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
nick_newbie
New Member
18
56
Mar 2026
Virginia
Online
Oct 14, 2023 at 3:41 AM#4

Exactly this. My pharmacist said the same thing about Any EU members.

27 5LarryQC_SD, wanda_boise, NurseAsh_DET and 24 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Oct 14, 2023 at 3:58 AM#5

As a pharmacist, I want to add some clinical context to this discussion on Any EU members finding it impossible to.

Building on what TomFromTexas said — the evidence base here is robust. The key publications to reference are from the SUSTAIN program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
22 18kim_atl_prep, sarah_TO, wendy_avl and 19 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register